CAPR - CAPRICOR THERAPEUTICS, INC.

QQQ $ 620.33 $ 0.00 (0 %)

DIA $ 473.88 $ 0.00 (0 %)

SPY $ 679.71 $ 0.00 (0 %)

TLT $ 89.45 $ 0.00 (0 %)

GLD $ 380.40 $ 0.00 (0 %)

Previous Close

$ 5.56

Open

$ 6.00

Bid

$ 5.70 x 100

Ask

$ 5.89 x 300

Day's Range

-- - --

52 Week Range

$ 5.43 - $ 20.75

Volume

3,939,206

Average Volume

Market Cap

254.19M

Beta (5Y Monthly)

$ 1.18

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-10-2025	09-30-2025	10-Q
2	08-11-2025	06-30-2025	10-Q
3	05-14-2025	03-31-2025	10-Q
4	03-26-2025	12-31-2024	10-K
5	11-14-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-14-2024	03-31-2024	10-Q
8	03-11-2024	12-31-2023	10-K
9	11-14-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-12-2023	03-31-2023	10-Q
12	03-17-2023	12-31-2022	10-K
13	11-10-2022	09-30-2022	10-Q
14	08-12-2022	06-30-2022	10-Q
15	05-11-2022	03-31-2022	10-Q
16	03-11-2022	12-31-2021	10-K
17	11-11-2021	09-30-2021	10-Q
18	08-13-2021	06-30-2021	10-Q
19	05-14-2021	03-31-2021	10-Q
20	03-15-2021	12-31-2020	10-K
21	11-13-2020	09-30-2020	10-Q
22	08-10-2020	06-30-2020	10-Q
23	05-15-2020	03-31-2020	10-Q
24	03-27-2020	12-31-2019	10-K
25	11-08-2019	09-30-2019	10-Q
26	08-08-2019	06-30-2019	10-Q
27	05-14-2019	03-31-2019	10-Q
28	03-29-2019	12-31-2018	10-K
29	11-14-2018	09-30-2018	10-Q
30	08-13-2018	06-30-2018	10-Q
31	05-14-2018	03-31-2018	10-Q
32	03-22-2018	12-31-2017	10-K
33	11-14-2017	09-30-2017	10-Q
34	08-14-2017	06-30-2017	10-Q
35	05-15-2017	03-31-2017	10-Q
36	03-16-2017	12-31-2016	10-K
37	11-14-2016	09-30-2016	10-Q
38	08-15-2016	06-30-2016	10-Q
39	05-13-2016	03-31-2016	10-Q
40	03-30-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Capricor Therapeutics Q3 EPS $(0.54) Beats...
11/10/2025 21:04:37

Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of...

top-stocks-with-earnings-this-week-plug-oklo-circle-and-more

Top Stocks With Earnings This Week: Plug, ...
11/10/2025 13:38:37

Here's a look at this week's earnings reports that are most likely to be watched by retail investors, including Oklo, P...

Earnings Scheduled For November 10, 2025
11/10/2025 11:12:02

Preview: Capricor Therapeutics's Earnings
11/07/2025 19:04:48

Capricor Therapeutics Publishes Peer-Revie...
11/03/2025 14:27:55

–Publication highlights Deramiocel's anti-fibrotic activity and describes a validated potency assay supporting quality cont...

HC Wainwright & Co. Reiterates Buy on Capr...
09/25/2025 15:41:12

HC Wainwright & Co. analyst Joseph Pantginis reiterates Capricor Therapeutics (NASDAQ: CAPR) with a Buy and maintains $2...

why-capricor-therapeutics-stock-is-surging-today

Why Capricor Therapeutics Stock Is Surging...
09/25/2025 15:16:22

Shares of Capricor Therapeutics Inc. (NASDAQ: CAPR) are up Thursday after the company announced progress regarding one of its r...

Capricor Issues BLA Update For DMD Cell Th...
09/25/2025 11:18:09

FDA and Capricor aligned on endpoints for HOPE-3 pivotal trialHOPE-3 pivotal trial completed; topline data expected mid-Q4 2025...

HC Wainwright & Co. Reiterates Buy on Capr...
09/11/2025 15:16:22

HC Wainwright & Co. analyst Joseph Pantginis reiterates Capricor Therapeutics (NASDAQ:CAPR) with a Buy and maintains $24...

Capricor Therapeutics Files For Mixed Shel...
09/11/2025 00:06:37

- SEC Filing

Capricor Responds To FDA's Unexpected Publ...
09/09/2025 13:21:04

Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for ...

4-biotech-stocks-that-are-showing-weakness-momentum-scores-fading-over-the-past-week

4 Biotech Stocks That Are Showing Weakness...
09/03/2025 10:21:00

Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stoc...

biohaven-advances-toward-potential-first-fda-approved-therapy-for-spinocerebellar-ataxia-fda-drops-advisory-meeting

Biohaven Advances Toward Potential First F...
08/22/2025 13:14:12

Biohaven shares rise as FDA removes advisory committee meeting for troriluzole in spinocerebellar ataxia, with decision expecte...

Capricor Therapeutics Announces First Subj...
08/18/2025 13:14:57

First-in-human trial of Capricor's StealthX™ vaccine initiated under HHS's Project NextGenTrial conducted and funded by...

Capricor Therapeutics Q2 EPS $(0.57) Misse...
08/11/2025 21:24:16

Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate ...

c3ai-destiny-tech100-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

C3.ai, Destiny Tech100 And Other Big Stock...
08/11/2025 12:45:18

why-international-money-express-shares-are-trading-higher-by-around-54-here-are-20-stocks-moving-premarket

Why International Money Express Shares Are...
08/11/2025 09:22:11

Capricor Therapeutics Announces Type A Mee...
08/08/2025 12:31:44

12 Health Care Stocks Moving In Wednesday'...
07/30/2025 17:07:24

whats-going-on-with-sarepta-capricor-and-other-gene-therapy-stocks-on-wednesday

What's Going On With Sarepta, Capricor And...
07/30/2025 15:07:26

Vinay Prasad exits FDA's biologics division following pressure over Sarepta's Elevidys approval and regulatory controve...